Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA in Early Parkinson's Disease
NCT03840005Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Dec 2018
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in Parkinson's disease (PD), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Dec 2018; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03840005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840005.